People With Gout at Risk for Chronic Opioid Use
Lindsay N. Helget MD University of Nebraska Medical Center A new study from the Veterans Health Administration (VA)…
Is a statin drug right for you? Researchers try to right-size the risk
It’s a math problem with life-and-death consequences. When a new and improved model for estimating the risk of…
Patients Prioritize Efficacy in Food Allergy Treatment Over Method, Frequency
Alexis T. Mickle, MSc Credit: LinkedIn In a discrete choice experiment, US patients tended to prefer more efficacious,…
Rocket Pharma’s shares soar after US FDA lets gene therapy trial resume
Rafael Henrique | SOPA Images | AP The U.S. health regulator has allowed a study of Rocket Pharmaceuticals’…
Cervical Cancer, Hodgkin Lymphoma Increase ASCVD Risk
New prospective cohort research has found that cervical cancer or Hodgkin lymphoma was associated with an increased risk…
Liver Stiffness and Fat Content May Lead to Coronary Heart Disease, Study Suggests
A recent retrospective study has demonstrated the nonlinear positive correlation between liver stiffness and fat content and coronary…
Systemic Inflammation Increases Healthcare Costs and Resource Utilization in ASCVD, CKD
New research is shedding light on stark increases in healthcare resource utilization and costs among individuals with atherosclerotic…
Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients, in support of patient access to authentic, FDA-approved semaglutide medicines
Ozempic® is the GLP-1 with the most FDA-approved uses for patients with type 2 diabetes including, improvement of…
Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
First Breakthrough Therapy Designation in the U.S. for SystImmune and Bristol Myers Squibb’s Izalontamab brengitecan (Iza-bren) based on data…
What are PBMs? How a bipartisan push could affect prescriptions
Lawmakers say middlemen in the prescription drug pipeline are limiting access to medications and driving up costs.See the…
Wealthy countries pay more for essential medicines, but the cost burden is far lower, study finds
Published on 17/08/2025 – 9:30 GMT+2 ADVERTISEMENT Wealthy countries may pay steep prices for medicines, but once their…
Guideline Implementation and Dose Titration Reduces Heart Failure Outcomes
Primary results of the TITRATE-HF study have shown the importance of early and intensive implementation of guideline-recommended medical…